The Global Preclinical Imaging (In-VIVO) Market size is expected to grow at an annual average of 5.3% during 2021-2027. Preclinical imaging is the visualization of living animals for research purposes such as drug development. Imaging modalities have long been important to researchers observing changes at the organ, tissue, cellular or molecular level in animals in response to physiological or environmental changes. Non-invasive and in vivo imaging modalities have become particularly important for longitudinal study of animal models.
(Get 15% Discount on Buying this Report)
A full report of Global Preclinical Imaging (In-VIVO) Market is available at: https://www.orionmarketreports.com/preclinical-imaging-in-vivo-market/57662/
The following Segmentation are covered in this report:
by Modality
- Optical Imaging Systems
- Preclinical Nuclear Imaging Systems
- Micro-MRI Systems
- Micro-Ultrasound Systems
- Micro-CT Systems
- Preclinical Photoacoustic Imaging Systems
- Preclinical Magnetic Particle Imaging (MPI) Systems
by Reagents
- Preclinical Optical Imaging Reagents
- Preclinical Nuclear Imaging Reagents
- Preclinical MRI Contrast Agents
- Preclinical Ultrasound Contrast Agents
- Preclinical CT Contrast Agents
The report covers the following objectives:
- Proliferation and maturation of trade in the global Preclinical Imaging (In-VIVO) Market.
- The market share of the global Preclinical Imaging (In-VIVO) Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Preclinical Imaging (In-VIVO) Market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Preclinical Imaging (In-VIVO) Market.
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
